Literature DB >> 8094898

Drug-induced gynecomastia.

D F Thompson1, J R Carter.   

Abstract

Gynecomastia is a relatively common physical finding in men. A wide variety of drugs have been implicated in its cause. Sufficient evidence in the literature suggests that calcium-channel blockers, cancer chemotherapeutic agents, and histamine2-receptor blockers may play a role in the disorder. Evidence for digitalis glycosides and neuroleptic agents is insufficient. Ketoconazole and spironolactone can also produce gynecomastia, and data for marijuana are contradictory. Large numbers of drugs have only case reports of temporal association with the disorder.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094898

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  15 in total

1.  Gynecomastia induced by treatment with tandospirone, a 5-HT1A agonist.

Authors:  Y Kaneda; T Morimoto; A Fujii
Journal:  J Psychiatry Neurosci       Date:  2001-03       Impact factor: 6.186

2.  Drug-induced gynecomastia in children and adolescents.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275

Review 3.  A comparative review of the adverse effects of calcium antagonists.

Authors:  H T Dougall; J McLay
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

4.  Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.

Authors:  Andrew G Warrilow; Josie E Parker; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

Review 5.  Resistance to antifungals that target CYP51.

Authors:  Josie E Parker; Andrew G S Warrilow; Claire L Price; Jonathan G L Mullins; Diane E Kelly; Steven L Kelly
Journal:  J Chem Biol       Date:  2014-08-27

Review 6.  Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

Authors:  Sankar D Navaneethan; Sagar U Nigwekar; Ashwini R Sehgal; Giovanni F M Strippoli
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

7.  Gynecomastia in subjects with sexual dysfunction.

Authors:  E Maseroli; G Rastrelli; G Corona; V Boddi; A M L Amato; E Mannucci; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2014-02-11       Impact factor: 4.256

Review 8.  Diagnosis and Management of Gynecomastia for Urologists.

Authors:  Lee Baumgarten; Ali A Dabaja
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

9.  Dimethandrolone (7alpha,11beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase.

Authors:  Barbara J Attardi; Trung C Pham; Lisa C Radler; Janet Burgenson; Sheri A Hild; Jerry R Reel
Journal:  J Steroid Biochem Mol Biol       Date:  2008-06       Impact factor: 4.292

Review 10.  Gynecomastia and hypertension.

Authors:  L Michael Prisant; Edward Chin
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.